Cycurion, Inc. Highlights $69 Million Contracted Backlog

Core Viewpoint - Cycurion, Inc. has a strong outlook for 2026, supported by a robust $69 million contracted backlog and an active sales pipeline in the hundreds of millions, despite challenges faced in 2025 [1][2][3] Group 1: Financial Performance and Outlook - The company secured new multi-year contracts totaling $69 million in 2025, with a weighted average life of 1-5 years, which is incremental to existing revenue [2] - Currently, Cycurion is operating at a $16 million annualized run-rate revenue, indicating a fundamental trough, but management anticipates a return to revenue growth and positive adjusted EBITDA in the coming quarters [3] - The company believes that its current share price presents a limited opportunity for investors to enter into a highly positive asymmetric risk/reward investment proposition [3] Group 2: Strategic Partnerships and Market Position - Cycurion has established notable partnerships with global IT and telecom providers, such as iQSTEL and LSV Tech, which enhance its market position [3] - The company has gained access to approximately 3,500 state and local healthcare associations through its association with NAACHO, further strengthening its growth prospects [3] Group 3: Commitment to Shareholders - The company is committed to delivering improved results for shareholders as it moves into 2026 and beyond, with plans to announce meaningful new awards and updates on its contracted backlog [4]